GlycoMimetics Inc (GLYC)
0.2675
-0.01
(-2.05%)
USD |
NASDAQ |
Jul 05, 15:40
GlycoMimetics SG&A Expense (TTM): 18.78M for March 31, 2024
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 18.78M |
December 31, 2023 | 19.21M |
September 30, 2023 | 19.63M |
June 30, 2023 | 18.96M |
March 31, 2023 | 19.55M |
December 31, 2022 | 19.09M |
September 30, 2022 | 18.90M |
June 30, 2022 | 19.20M |
March 31, 2022 | 17.98M |
December 31, 2021 | 17.12M |
September 30, 2021 | 16.58M |
June 30, 2021 | 16.49M |
March 31, 2021 | 16.49M |
December 31, 2020 | 16.74M |
September 30, 2020 | 16.60M |
June 30, 2020 | 15.92M |
March 31, 2020 | 15.44M |
December 31, 2019 | 14.36M |
September 30, 2019 | 13.41M |
June 30, 2019 | 12.82M |
March 31, 2019 | 11.92M |
December 31, 2018 | 11.41M |
Date | Value |
---|---|
September 30, 2018 | 11.31M |
June 30, 2018 | 10.92M |
March 31, 2018 | 8.076M |
December 31, 2017 | 7.313M |
September 30, 2017 | 6.795M |
June 30, 2017 | 6.377M |
March 31, 2017 | 8.686M |
December 31, 2016 | 8.650M |
September 30, 2016 | 8.313M |
June 30, 2016 | 8.462M |
March 31, 2016 | 7.956M |
December 31, 2015 | 7.805M |
September 30, 2015 | 7.961M |
June 30, 2015 | 7.476M |
March 31, 2015 | 7.275M |
December 31, 2014 | 6.595M |
September 30, 2014 | 5.302M |
June 30, 2014 | 4.454M |
March 31, 2014 | 3.517M |
December 31, 2013 | 2.898M |
September 30, 2013 | 2.618M |
June 30, 2013 | 2.368M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (TTM) Range, Past 5 Years
13.41M
Minimum
Sep 2019
19.63M
Maximum
Sep 2023
17.39M
Average
17.12M
Median
Dec 2021
SG&A Expense (TTM) Benchmarks
Lyell Immunopharma Inc | 61.20M |
Amicus Therapeutics Inc | 289.34M |
Insmed Inc | 357.69M |
InfuSystems Holdings Inc | 59.82M |
Nanoviricides Inc | 2.633M |